EAACI Congress 2025

Back
13 - 16 June 2025 Glasgow, United Kingdom

TPS69 - Allied health and primary care

Sunday 15 Jun, 12:45 PM - 13:45 PM Glasgow, United Kingdom
Poster Zone Thematic Poster Session
Anxiety Associated with Parenteral On-Demand Treatment for Hereditary Angioedema Attacks in Patients from Italy
China's Hypoallergenic Home Visit Program: A Standardized Process for Environmental Control Based on a Mobile Application
Daily life with a peanut allergy, as a young adult- an interview study
Deep Learning-Based Real-Time Identification of Wheezing in Lung Sounds: Applications in Disease Prediction and Early Intervention
Evaluation for suspected penicillin allergy - the patient perspective
Evidence summary of indoor environmental controls in dust mite allergic patients
Food provision experience of inpatients with adverse food reactions in the acute hospital setting
Rationale and Design for ALPHA-ORBIT: a phase 3 trial of navenibart, a monoclonal antibody inhibitor of plasma kallikrein for participants with hereditary angioedema (HAE)
Results from the ALPHA-STAR Trial, a Phase 1b/2 Single and Multiple Dose Study to Assess the Safety, Tolerability, Clinical Activity, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Navenibart in Participants with Hereditary Angioedema (HAE)
What information and education is crucial for people with food allergies?

Speakers